Literature DB >> 24266967

Repression of Farnesoid X receptor contributes to biliary injuries of liver grafts through disturbing cholangiocyte bile acid transport.

L Cheng1, F Tian, F Tian, L Tang, G Chen, Z Luo, J Ren, S Wang.   

Abstract

Biliary epithelial damage is the critical point in the development of nonanastomotic strictures, a serious biliary complication after liver transplantation (LT). Current study focuses on the roles and mechanisms of unbalanced bile acid (BA) transporting of cholangiocytes in biliary epithelial damages following LT. Using rat LT models, we observed that biliary transit time (BTT) of BA was prolonged, and the degree and duration of BTT prolongation were related to the cold ischemia time of donor liver. Moreover, prolonged BTT was correlated with bile duct injury severity. The expression of Farnesoid X receptor (FXR) underwent a dramatic decrease after transplantation, and the decrease in FXR was related to cold ischemic time of donor liver. Negative correlation was observed between FXR expression and BTT. With in vitro cultured human biliary epithelial cells, it was observed that FXR expressions and DNA binding activities were repressed under hypoxic conditions. FXR repression by hypoxia mediated unparallel expressions of BA transporters and intracellular accumulation of BAs, which induced higher cell apoptosis rates and enhanced profibrotic factor expression in cholangiocytes. These findings indicated that FXR repression under ischemic/hypoxic conditions contributed to biliary epithelial damages by disturbing BA transporting of cholangiocytes after LT. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Bile acid transporters; Farnesoid X receptor; bile duct injury; biliary epithelial cells; liver transplantation

Mesh:

Substances:

Year:  2013        PMID: 24266967     DOI: 10.1111/ajt.12479

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

2.  Risk factors and clinical indicators for the development of biliary strictures post liver transplant: Significance of bilirubin.

Authors:  Elizabeth Ann Forrest; Janske Reiling; Geraldine Lipka; Jonathan Fawcett
Journal:  World J Transplant       Date:  2017-12-24

3.  Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.

Authors:  Dan Jin; Tianfei Lu; Ming Ni; Han Wang; Jiang Zhang; Chenpeng Zhong; Chuan Shen; Jun Hao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Jianjun Zhang; Ning Xu; Yuan Zhai
Journal:  Hepatol Commun       Date:  2020-02-13

Review 4.  Bile acid signaling and biliary functions.

Authors:  Hannah Jones; Gianfranco Alpini; Heather Francis
Journal:  Acta Pharm Sin B       Date:  2015-02-19       Impact factor: 11.413

5.  Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage.

Authors:  Zhibo Gai; Lei Chu; Zhenqiang Xu; Xiaoming Song; Dongfeng Sun; Gerd A Kullak-Ublick
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

6.  Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation.

Authors:  Andrie C Westerkamp; Masato Fujiyoshi; Petra J Ottens; Maarten W N Nijsten; Daan J Touw; Vincent E de Meijer; Ton Lisman; Henri G D Leuvenink; Han Moshage; Tim A Berendsen; Robert J Porte
Journal:  Transplantation       Date:  2020-09       Impact factor: 5.385

7.  Bile Acids and FXR: Novel Targets for Liver Diseases.

Authors:  Mary Stofan; Grace L Guo
Journal:  Front Med (Lausanne)       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.